Stay updated on Ivacaftor Safety in Infants Clinical Trial
Sign up to get notified when there's something new on the Ivacaftor Safety in Infants Clinical Trial page.

Latest updates to the Ivacaftor Safety in Infants Clinical Trial page
- Check6 days agoChange DetectedThe clinical-trial record for the long-term ivacaftor study in infants with cystic fibrosis is displayed instead of a forbidden-error page, with details on the study design, eligibility, locations, outcomes, and supporting documents.SummaryDifference57%

- Check13 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check20 days agoChange DetectedA sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across agency content.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now displays a 403 Forbidden error, indicating access is blocked, with the standard site header and a minimal footer visible on the error page.SummaryDifference18%

Stay in the know with updates to Ivacaftor Safety in Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivacaftor Safety in Infants Clinical Trial page.